How Lung Cancers Shed Their Identity to Outsmart KRAS Drugs
A new mouse study shows that lung adenocarcinomas can evade KRAS inhibitors by reprogramming their cellular identity through transcription factors ...
A new mouse study shows that lung adenocarcinomas can evade KRAS inhibitors by reprogramming their cellular identity through transcription factors ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine